Nanomedicine News

RSS

Selecta Presents New Advancements at the American Society for Nanomedicine Annual Meeting

Selecta Biosciences, Inc., a clinical stage biotechnology company developing a novel class of targeted antigen-specific immune therapies, announced today that its Chief Scientific Officer, Takashi Kei Kishimoto, PhD, presented new advancements related to Selecta’s pipeline of novel immunotherapeutic candidates at the 5th Annual American Society for Nanomedicine Meeting in Crystal City, Virginia.

19 Oct 2015

Enrollment Complete in Cerulean CRLX101 NDC-Avastin Combination Phase 2 Trial in RCC

Cerulean Pharma Inc., a clinical stage company developing nanoparticle-drug conjugates (NDCs), today announced completion of enrollment of a randomized Phase 2 trial of its lead NDC, CRLX101, in combination with Avastin®, in third- and fourth-line relapsed renal cell carcinoma (RCC). The trial has enrolled all 110 patients and the company expects to announce top-line data in the first half of 2016.

16 Oct 2015

Matinas BioPharma to Provide Update on MAT2203 Phase 2a Clinical Study at 14th Annual BIO Investor Forum

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective therapeutics for the treatment of serious and life-threatening infections, today announced that it will be presenting at the 14th Annual BIO Investor Forum being held October 20-21, 2015, at the Parc 55 in San Francisco, California.

15 Oct 2015

Nanomedical Diagnostics Completes $1.6 Million Series A Financing Round

Nanomedical Diagnostics, a biotech company developing and commercializing bioelectronics for use in research and diagnostics, announces the completion of a Series A financing round of $1.6 million led by Serra Ventures.

15 Oct 2015

Laser-Based Stimulated Raman Scattering Microscopy Could Help Differentiate Between Tumor Tissue and Normal Brain

Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it.

15 Oct 2015

New Tool to Identify Unstable or High Risk Atherosclerotic Plaques

Researchers have developed and validated a new tool to help identify unstable or high risk atherosclerotic plaques--inflamed fatty deposits in the artery wall and a main contributor to cardiovascular disease (CVD). This breakthrough may lead to better identifying which plaques are considered at the highest risk for rupturing and causing a heart attack or stroke.

14 Oct 2015

Providence Introduces Nano-Textured Surface Technology to DTRAX Line of Tissue-Sparing Devices to Enhance Cervical Fusion Process

Providence Medical Technology, Inc., an innovator in tissue-sparing cervical spine technology, today introduced its proprietary Cavux™ surface technology, designed to speed bone fusion during the healing process. The company’s portfolio of DTRAX® Cervical Cage implants will be available with Cavux, a unique surface technology that produces micro-textures on titanium surfaces. The micro- and nano-textures created across the implant surface area serve to enhance the fusion process.

14 Oct 2015

Computational Modeling Enables Design of Sturdier Liposome

Using computational modeling, researchers at Carnegie Mellon University, the Colorado School of Mines and the University of California, Davis have come up with a design for a better liposome. Their findings, while theoretical, could provide the basis for efficiently constructing new vehicles for nanodrug delivery.

14 Oct 2015

ETPN to Help EU Companies Bring Innovative Nanomedicines to Market

Patrick Boisseau, chairman of the European Technology Platform on Nanomedicine (ETPN), said today that nanomedicine in Europe is rapidly progressing from a primarily academic-research-oriented and fragmented field to a multi-national program sharply focused on bringing the benefits of nanomedicine to all Europeans.

From CEA-Leti 14 Oct 2015

NCI Awards Five-Year, $1.8 Million Training Grant for Nanotechnology to Treat Cancer

Rice University and the University of Texas MD Anderson Cancer Center have won a five-year, $1.8 million grant from the National Cancer Institute (NCI) to train graduate students and postdoctoral research associates to translate nanotechnology breakthroughs into clinical treatments for cancer patients.

13 Oct 2015

Nanomedicine News

Selecta Presents New Advancements at the American Society for Nanomedicine Annual Meeting

Enrollment Complete in Cerulean CRLX101 NDC-Avastin Combination Phase 2 Trial in RCC

Matinas BioPharma to Provide Update on MAT2203 Phase 2a Clinical Study at 14th Annual BIO Investor Forum

Nanomedical Diagnostics Completes $1.6 Million Series A Financing Round

Laser-Based Stimulated Raman Scattering Microscopy Could Help Differentiate Between Tumor Tissue and Normal Brain

New Tool to Identify Unstable or High Risk Atherosclerotic Plaques

Providence Introduces Nano-Textured Surface Technology to DTRAX Line of Tissue-Sparing Devices to Enhance Cervical Fusion Process

Computational Modeling Enables Design of Sturdier Liposome

ETPN to Help EU Companies Bring Innovative Nanomedicines to Market

NCI Awards Five-Year, $1.8 Million Training Grant for Nanotechnology to Treat Cancer

Nanopore-Based Sensor Enables Rapid and Precise Disease Diagnosis

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Brain-Inspired Nano-Tech Promises New Era for Electronics

Conversations on AFM: Applications of BioAFM in Life Science

Conversations on AFM: The Technology and History Behind AFM and SPM

Recent Advances in High-Speed Atomic Force Microscopy to Improve Research Into Protein Dynamics

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials